Paul Hoelscher Net Worth & Insider Trades
Paul Hoelscher - EVP, Horizon Therapeutics Public Ltd Co
What is Paul Hoelscher's Net Worth?
The current estimated net worth of Horizon Therapeutics Public Ltd Co's EVP, Paul Hoelscher, is estimated to be about $87.72M . Paul Hoelscher owns about 73,838 units of Horizon Therapeutics Public Ltd Co common stock. In the last 8 years at Horizon Therapeutics Public Ltd Co, Paul Hoelscher has sold an estimated value of $84.14M worth.
What is Paul Hoelscher's Past Insider Trading?
Paul Hoelscher's largest purchase order was 215,335 units , worth over $4.58M on April 8, 2022. Paul Hoelscher's largest sale order was 307,045 units , worth over $33.78M on April 8, 2022. In total, Paul Hoelscher has made about 30 transactions over 8 years of their time at Horizon Therapeutics Public Ltd Co. Paul Hoelscher usually trades in January, with the busiest year in 2021, 2020 and 2019. The most recent transaction was a sale order of 50,000 units , worth over $5.74M on April 22, 2022.
Paul Hoelscher
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What was Paul Hoelscher's Salary in 2020?
As EVP of Horizon Therapeutics Public Ltd Co, Paul Hoelscher has a total base salary of $600,569 . Paul Hoelscher received compensation valued at about $5,915,146 in 2020 after becoming EVP. The vast majority of their compensation came in the form of other earnings, plans or compensations of $106,485 , other earnings, plans or compensations of $106,485 , other earnings, plans or compensations of $106,485 , and other earnings, plans or compensations of $106,485 .
What is Paul Hoelscher's' Mailing Address?
- Mailing address is 520 Lake Cook Road, Suite 520 C/o Horizon Pharma, Inc. Deerfield IL 60062 IL
Horizon Therapeutics Public Ltd Co Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
|---|---|---|---|---|---|---|---|---|
| Timothy P. Walbert | 2020 | $1,146,542 | - | $199,548 | $199,548 | $199,548 | $199,548 | $21,632,803 |
| Timothy P. Walbert | 2019 | $1,108,700 | - | $226,871 | $226,871 | $226,871 | $226,871 | $13,873,172 |
| Timothy P. Walbert | 2018 | $1,076,250 | - | $160,363 | $160,363 | $160,363 | $160,363 | $16,796,894 |
| Paul W. Hoelscher | 2020 | $600,569 | - | $106,485 | $106,485 | $106,485 | $106,485 | $5,915,146 |
| Paul W. Hoelscher | 2019 | $580,748 | - | $120,135 | $120,135 | $120,135 | $120,135 | $4,443,588 |
| Paul W. Hoelscher | 2018 | $563,750 | - | $104,332 | $104,332 | $104,332 | $104,332 | $7,034,386 |
| Andy Pasternak | 2020 | $669,021 | $250,000 | $66,872 | $66,872 | $66,872 | $66,872 | $5,826,126 |
| Andy Pasternak | 2019 | $108,333 | $500,000 | $19,188 | $19,188 | $19,188 | $19,188 | $2,924,542 |
| Jeffrey W. Sherman, M.D., FACP | 2020 | $578,731 | - | $92,545 | $92,545 | $92,545 | $92,545 | $5,261,300 |
| Jeffrey W. Sherman, M.D., FACP | 2019 | $559,630 | - | $95,222 | $95,222 | $95,222 | $95,222 | $3,568,496 |
| Jeffrey W. Sherman, M.D., FACP | 2018 | $543,250 | - | $68,263 | $68,263 | $68,263 | $68,263 | $3,678,874 |
| Barry J. Moze | 2020 | $628,960 | - | $75,659 | $75,659 | $75,659 | $75,659 | $5,073,877 |
| Barry J. Moze | 2019 | $608,201 | - | $58,744 | $58,744 | $58,744 | $58,744 | $4,662,510 |
| Barry J. Moze | 2018 | $590,400 | - | $35,114 | $35,114 | $35,114 | $35,114 | $2,732,565 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm
What are Horizon Therapeutics Public Ltd Co's Past Insider Trades?
Horizon Therapeutics Public Ltd Co's most recent insider trade came on January 18, 2023 by Andy Pasternak who sold 27,129 units worth $3.07M . In the last 12 years, insiders at Horizon Therapeutics Public Ltd Co have sold an estimated value of $733.13M and bought an estimated value of $120.28M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman, Jeffrey Sherman, EVP and Chief Medical Officer, and Paul Hoelscher, EVP .
Horizon Therapeutics Public Ltd Co Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||